Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

    ... lenalidomide , hypomethylating agents, intensive chemotherapy , and allogeneic stem cell transplantation. The use of ...

    Research Article last updated 02/04/2014 - 1:37pm.

  2. The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.

    ... yrs were more likely to receive active therapies (i.e., chemotherapy , immunomodulatory therapy, or epigenetic therapy) than ...

    Research Article last updated 10/22/2013 - 2:33pm.

  3. Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study

    ... received disease-modifying therapies (DMT) that included chemotherapy (CHT) for 65 patients, allogeneic stem-cell transplantation ...

    Research Article last updated 04/02/2013 - 7:59am.

  4. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

    ... studies have identified poor-risk cytogenetics , chemotherapy resistance, comorbidities from prior cancer and therapy, and ...

    Research Article last updated 02/04/2013 - 2:51pm.

  5. Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

    ... hematopoietic growth factors, hypomethylating agents, chemotherapy or transplantation) , progression to acute myeloid leukemia, ...

    Research Article last updated 11/19/2012 - 2:37pm.

  6. Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies

    ... treatment prior to transplantation, including induction chemotherapy (ICT) alone (ICT group; n = 98), AZA alone (AZA group; n = ...

    Research Article last updated 11/05/2012 - 8:57am.

  7. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes

    ... elderly patients and those with prior exposure to chemotherapy , radiation, and environmental toxins in the presence of ...

    Research Article last updated 07/31/2012 - 1:03pm.

  8. Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia

    ... salicylate may be safely combined with conventional chemotherapy regimens which are not associated with significant ototoxicity ...

    Research Article last updated 01/09/2012 - 2:21pm.

  9. Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?

    ... antigen -compatible donor, autologous SCT, or chemotherapy may be good alternatives for those with MDS and with good-risk ...

    Research Article last updated 11/16/2011 - 2:15pm.

  10. Infections in patients with aplastic anemia.

    ... with AA and the patient who is neutropenic due to chemotherapy and this leads to a difference in the infections that they ...

    Research Article last updated 10/11/2011 - 5:58pm.